Antibe Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 07 Mar 24 | Buy€6,795 | Daniel Legault | Individual | 20,000 | €0.34 | |
| 07 Mar 24 | Buy€5,300 | Scott Curtis | Individual | 15,000 | €0.35 | |
| 06 Mar 24 | Buy€8,806 | Joseph Stauffer | Individual | 24,000 | €0.37 |
Insider Trading Volume
Insider Buying: 4B70 insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Private Companies | 173,089 | 0.327% |
| Institutions | 240,000 | 0.453% |
| Individual Insiders | 1,636,495 | 3.09% |
| General Public | 50,959,778 | 96.1% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 1,129,396 | €224.7k | 1.8% | no data | |||
| 254,819 | €50.7k | 33.3% | no data | |||
| 240,000 | €47.8k | 0% | no data | |||
| 173,089 | €34.4k | 69% | no data | |||
| 115,000 | €22.9k | 15% | no data | |||
| 68,918 | €13.7k | 0% | no data | |||
| 41,700 | €8.3k | 0% | no data | |||
| 26,662 | €5.3k | 0% | no data |